Crescent Biopharma CBIO
NASDAQ CBIO
$16.23 -1.09 (-6.29%)
At close: Aug 20, 2026 · 4:00 PM EDT

Crescent Biopharma (CBIO) Return on Sales (2013 - 2026)

Crescent Biopharma (CBIO) posted quarterly Return on Sales of 2.22% for Q2 2026, down 202.74% quarter-over-quarter from 0.73% in Q1 2026.

Crescent Biopharma (CBIO) Return on Sales (2013 - 2026) Analysis & Trends

Crescent Biopharma (CBIO) has reported Return on Sales for 10 consecutive years, with 2.22% the latest figure, recorded in Q2 2026.

  • In Q2 2026, Return on Sales changed N/A year-over-year to 2.22%; the TTM figure through Jun 2026 stood at 2.22% (changed N/A YoY), while the FY2025 annual figure was 0.14%, changed N/A from the prior year.
  • Return on Sales fell to 2.22% in Q2 2026 per CBIO's latest filing, from 0.73% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.73% in Q1 2026 and bottomed at 6.47% in Q4 2024.
  • Historically, Return on Sales has averaged 3.21% across 3 years, with a median of 2.61% in 2022.
  • On a YoY basis, Return on Sales climbed as much as 101226 bps in 2022 and fell as far as 100 bps in 2022.
  • Crescent Biopharma's Return on Sales stood at 5.04% in 2022, then decreased by 28 bps to 6.47% in 2024, then jumped by 66 bps to 2.22% in 2026.
  • Business Quant data shows CBIO's Return on Sales at 2.22% in Q2 2026, 0.73% in Q1 2026, and 6.47% in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 0.00%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 0.00%
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -0.05%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 0.00%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 0.00%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 0.00%
8 Royalty Pharma 26.98 Bn 26.14 Bn - 0.00%
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 0.00%
10 Crescent Biopharma 1.05 Bn 875.92 Mn - -1.57%

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.22%
Mar 31, 2026 -0.73%
Dec 31, 2024 -6.47%
Dec 31, 2022 -5.04%
Sep 30, 2022 -3.01%
Jun 30, 2022 -1.77%
Dec 31, 2021 -9.88%
Sep 30, 2021 -2.00%
Jun 30, 2021 -1,014.03%
Mar 31, 2021 -0.14%
Dec 31, 2020 -0.96%
Sep 30, 2020 -0.14%
Jun 30, 2020 -0.06%
Mar 31, 2020 -0.01%
Sep 30, 2017 -64.48%
Jun 30, 2017 -18.97%
Mar 31, 2017 -10.70%
Sep 30, 2016 -4.86%
Dec 31, 2015 -13.66%
Sep 30, 2015 -2.03%